SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001513160-13-000034
Filing Date
2013-05-30
Accepted
2013-05-30 21:19:49
Documents
1
Period of Report
2013-05-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5570
  Complete submission text file 0001513160-13-000034.txt   7054
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 0528
SIC: 4731 Arrangement of Transportation of Freight & Cargo

Mailing Address 3651 BAKER HWY P.O. BOX 130 HUNTSVILLE TN 37756
Business Address
VOYTICKY DAVID J (Reporting) CIK: 0001490974 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53127 | Film No.: 13883358